Physicians' Intentions to Administer HPV Vaccine

医生接种 HPV 疫苗的意图

基本信息

  • 批准号:
    8073054
  • 负责人:
  • 金额:
    $ 7.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-05-15 至 2013-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cervical cancer, genital warts, and other health conditions associated with human papillomavirus (HPV) exact substantial morbidity, mortality, and expenses. In 2006, the Food and Drug Administration (FDA) approved a quadrivalent HPV vaccine for females ages 9-26, and the Advisory Committee on Immunization Practices (ACIP) recommended routine vaccination for girls ages 11-12. Modest vaccination rates to date, however, indicate problems with increasing coverage and adherence to the recommended vaccine schedule, and may presage difficulties in realizing the vaccine's public health promise. Provider-oriented issues and challenges related to vaccine implementation may have been underestimated and remain insufficiently studied, especially with regard to primary care physicians (PCPs), who are well suited to provide vaccine to most young females. The broad objective of this study is to identify the appropriate constellation of factors that differentially relate to clinicians' stated intentions to administer HPV vaccine as recommended. Our central hypothesis is that clinicians' attitudes, subjective norms, and perceptions of issues as barriers significantly influence their intentions to administer the vaccine and, ultimately, their behavior, as predicted by the theory of planned behavior (TPB). We propose four specific aims: 1) to develop a theoretically-informed survey questionnaire for the assessment of TPB-based and other measures of PCPs' intentions to administer the HPV vaccine; 2) to implement the survey questionnaire among PCPs in Alabama and Mississippi; 3) to examine PCP characteristics and TPB-based measures regarding intention to administer HPV vaccine under different conditions; and 4) to identify groups of PCPs who can be differentiated with respect to the patterns of functional relations between the TPB-factors and intentionality. Using nominal group technique meetings and other steps, the survey instrument will be developed, pre-tested and piloted with PCPs and family practice residents and faculty. At least 300 complete survey responses will be collected from PCPs to allow examination of our hypotheses and relationships between relevant variables and intentionality under different patient conditions. Intentionality will be operationalized through a series of behaviorally anchored case vignettes. PCPs' awareness and attitudes regarding ACIP recommendations will also be evaluated. The study will be administered in two states with high HPV-associated disease burdens, acute PCP shortages, and low HPV immunization rates. The proposed research will yield important information to improve understanding of theoretical predictors and provider-based barriers to HPV vaccination in actual practice. This should also suggest useful direction for developing provider-based strategies to increase the likelihood of vaccine administration that could be studied in future research. PUBLIC HEALTH RELEVANCE: HPV vaccination offers an effective prevention strategy for reducing the substantial morbidity and healthcare costs caused by persistent HPV infection, so long as problems besetting current modest vaccination rates are better understood and overcome. The proposed study will examine factors that differentially relate to clinicians' stated intentions to administer HPV vaccine, using new measures of intentionality and clinicians' evaluative perceptions of professional recommendations. Our work will help inform future research and the design of strategies to improve the likelihood that physicians would adopt recommendations for administering HPV vaccine.
描述(由申请人提供):宫颈癌、生殖器疣和其他与人乳头瘤病毒(HPV)相关的健康状况导致大量的发病率、死亡率和费用。2006年,美国食品和药物管理局(FDA)批准了9-26岁女性的四价HPV疫苗,免疫实践咨询委员会(ACIP)建议为11-12岁的女孩接种常规疫苗。然而,迄今为止的适度疫苗接种率表明,在扩大覆盖面和遵守推荐的疫苗接种时间表方面存在问题,并可能预示着在实现疫苗的公共卫生承诺方面存在困难。与疫苗实施有关的面向提供者的问题和挑战可能被低估,并且仍然没有得到充分的研究,特别是在初级保健医生方面,他们非常适合为大多数年轻女性提供疫苗。本研究的主要目的是确定与临床医生按照建议接种HPV疫苗的既定意图差异相关的适当因素。我们的中心假设是,临床医生的态度,主观规范,并作为障碍的问题的看法显着影响他们的意图管理疫苗,并最终,他们的行为,如计划行为理论(TPB)预测。我们提出四个具体目标:1)制定一份理论上知情的调查问卷,用于评估PCP接种HPV疫苗的意向的TPB和其他措施; 2)在亚拉巴马和密西西比的PCP中实施调查问卷; 3)检查PCP的特征和不同条件下HPV疫苗接种意向的TPB措施;(4)根据TPB因素与意向性之间的功能关系模式,确定可以区分的PCP群体。使用名义组技术会议和其他步骤,调查工具将开发,预测试和试点与PCP和家庭实践居民和教师。将从PCP中收集至少300份完整的调查问卷,以检查我们的假设以及不同患者条件下相关变量和意向之间的关系。意向性将通过一系列以行为为基础的案例小插曲来实现。还将评估初级专业人员对ACIP建议的认识和态度。该研究将在两个HPV相关疾病负担高、PCP严重短缺和HPV免疫率低的州进行。拟议的研究将产生重要的信息,以提高对理论预测因素和实际实践中HPV疫苗接种的提供者障碍的理解。这也应该为开发基于提供者的策略提供有用的方向,以增加疫苗接种的可能性,这可以在未来的研究中进行研究。 公共卫生相关性:HPV疫苗接种提供了一种有效的预防策略,可以降低持续性HPV感染引起的大量发病率和医疗费用,只要更好地理解和克服当前适度疫苗接种率所面临的问题。这项拟议的研究将使用新的意向性措施和临床医生对专业建议的评价性看法,研究与临床医生表示的接种HPV疫苗的意图有差异的因素。我们的工作将有助于为未来的研究和策略设计提供信息,以提高医生采用HPV疫苗接种建议的可能性。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDRZEJ KULCZYCKI其他文献

ANDRZEJ KULCZYCKI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDRZEJ KULCZYCKI', 18)}}的其他基金

Physicians' Intentions to Administer HPV Vaccine
医生接种 HPV 疫苗的意图
  • 批准号:
    7977815
  • 财政年份:
    2010
  • 资助金额:
    $ 7.25万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.25万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 7.25万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.25万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.25万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.25万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.25万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.25万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 7.25万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 7.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 7.25万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了